Skip to main content
Fig. 2 | BMC Gastroenterology

Fig. 2

From: Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study

Fig. 2

Kaplan–Meier survival curves for overall survival (OS) and progression-free survival (PFS) before propensity score matching (PSM). OS (A) and PFS (B) analyses for the AS (n = 62) and SOX (n = 81) regimens. OS (C) and PFS (D) analyses of gastric cancer patients with Lauren non-intestinal type (diffuse and mixed type). OS (E) and PFS (F) analyses of gastric cancer patients with Lauren diffuse type

Back to article page

BMC Gastroenterology

ISSN: 1471-230X

Contact us